Researchclopedia

Research Researchers Institutions Topics Submit About

Command Palette

Search for a command to run...

Researchclopedia

Research Researchers Institutions About

© 2026 Researchclopedia. Powered by OpenAlex under CC0 license.

François Guilhot | Researchclopedia

Back to researchers

François Guilhot

625

Works

42,799

Citations

84

h-index

296

i10-index

Research Topics

Chronic Myeloid Leukemia Treatments Chronic Lymphocytic Leukemia Research Eosinophilic Disorders and Syndromes

Affiliations

Université Paris-Sud2014–2014

Centre National de la Recherche Scientifique1989–2014

NorthShore University HealthSystem2003–2003

NewYork–Presbyterian Hospital2006–2006

Council of Independent Colleges2011–2011

Top Works

Imatinib Compared with Interferon and Low-Dose Cytarabine for Newly Diagnosed Chronic-Phase Chronic Myeloid Leukemia

Stephen G. O’Brien,François Guilhot,et al.

20033,549 citations

Acute Lymphoblastic Leukemia research

Acute Myeloid Leukemia Research

Five-Year Follow-up of Patients Receiving Imatinib for Chronic Myeloid Leukemia

Brian Druker,François Guilhot,et al.

20063,464 citations

Hematologic and Cytogenetic Responses to Imatinib Mesylate in Chronic Myelogenous Leukemia

Hagop Kantarjian,Charles L. Sawyers,et al.

20022,026 citations

European LeukemiaNet recommendations for the management of chronic myeloid leukemia: 2013

Michele Baccarani,Michael Deininger,et al.

20131,981 citations

Discontinuation of imatinib in patients with chronic myeloid leukaemia who have maintained complete molecular remission for at least 2 years: the prospective, multicentre Stop Imatinib (STIM) trial

François‐Xavier Mahon,Delphine Réa,et al.

20101,531 citations

European LeukemiaNet 2020 recommendations for treating chronic myeloid leukemia

Andreas Hochhaus,Michele Baccarani,et al.

20201,474 citations

Chronic Myeloid Leukemia: An Update of Concepts and Management Recommendations of European LeukemiaNet

Michele Baccarani,Jörge E. Cortes,et al.

20091,298 citations

Long-Term Outcomes of Imatinib Treatment for Chronic Myeloid Leukemia

Andreas Hochhaus,Richard A. Larson,et al.

20171,223 citations

A Phase 2 Trial of Ponatinib in Philadelphia Chromosome–Positive Leukemias

Jörge E. Cortes,D. W. Kim,et al.

20131,111 citations